FindTrial
Sign In

Usual Care with Attention Control

BEHAVIORAL2 trials

Sponsors

University of Vermont, Loma Linda University

Conditions

End Stage Renal DiseasePancreatic Cancer, AdultSevere Functional ImpairmentSevere Life-limiting COPDSevere Life-limiting CirrhosisSevere Life-limiting Heart FailureSevere Life-limiting Malignancy

Phase 2

Communication During Hospitalization About Resuscitation Trial
CompletedNCT02984124
University of VermontEnd Stage Renal Disease, Severe Functional Impairment, Severe Life-limiting Cirrhosis +3
Start: 2016-12-01End: 2025-12-01Updated: 2026-05-29

Unknown Phase

To Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDAC
RecruitingNCT07591571
Loma Linda UniversityPancreatic Cancer, Adult
Start: 2025-09-01End: 2026-09-01Target: 60Updated: 2026-05-15

Related Papers

A Pilot Randomized Controlled Trial to Evaluate the Preliminary Efficacy of PAL-CHW-PDAC, a Digitally Enhanced CHW-led Intervention to Facilitate Stepped Palliative Care in Patients with Pancreatic Cancer.
medRxiv2026-05-22